Oregon Department of Corrections
Approved Formulary
Search by name
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
February P&T meeting minutes have been posted.
Oregon Department of Corrections
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Search results for:
tofacitinib
tofacitinib
Hazardous Drugs
Handling Guide (Group 2: Non-Antineoplastics)
Brand names:
XELJANZ, XELJANZ XR
Form
Strength
TABLET, EXTENDED RELEASE, ORAL
11 mg; 22 mg
TABLET, ORAL
5 mg; 10 mg
Additional Information:
FEBRUARY 2023 P&T MINUTES
Last updated:
Mar. 13, 2023
UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier
FEBRUARY 2023 P&T MINUTES